Clinical trials: Thrombotic and Bleeding Events

Antithrombin III Deficiency

Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate

• Terminated
• Age: 12 years and older
• Phase 2/3
• Results posted

To assess the safety, pharmacokinetics and efficacy of a plasma-derived AT-III concentrate in the treatment of subjects with congenital AT-III deficiency.

Trial name

NCT00319228

Testing

Plasma-derived AT-III concentrate

Volunteers

3 people

Sponsor

Instituto Grifols, S.A.